Shapiro C M, Schifeling D, Bitran J D, Desser R K, Rochman H, Michel A, Shapiro R, Evans R, Kozloff M F, Recant W, Billings A A
J Surg Oncol. 1982 Feb;19(2):119-21. doi: 10.1002/jso.2930190216.
The relationship between estrogen receptor levels and recurrence of breast cancer was examined in 302 patients with adenocarcinoma of the breast, pathologic stage (PS) I and II. All 117 patients with PS II adenocarcinoma of the breast received adjunctive chemotherapy. In this series, there was no association between the estrogen receptor level and recurrence in either the 185 patients with PS I adenocarcinoma of the breast or the 117 patients with PS II adenocarcinoma of the breast. The most important prognostic variable was the presence or absence of axillary metastases.
对302例病理分期为I期和II期的乳腺腺癌患者，研究了雌激素受体水平与乳腺癌复发之间的关系。所有117例II期乳腺腺癌患者均接受了辅助化疗。在该系列研究中，雌激素受体水平与185例I期乳腺腺癌患者或117例II期乳腺腺癌患者的复发均无关联。最重要的预后变量是腋窝转移的有无。
